Registered Nurse in Sedalia, MO Accepting Medicare

8 Registered Nurse nurses found. Showing 1 - 8

Harlan Wayne Smither, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 601 E 14th St, Sedalia, MO 65301 Phone: 660-826-8833    Fax: 660-827-3742

Ms. Kelly R Gordon, RN ARNP CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3310 W 10th St, Sedalia, MO 65301 Phone: 660-829-4024

Jessica Marie Berney, FNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 821 Westwood Dr, Sedalia, MO 65301 Phone: 660-826-4774    Fax: 888-979-8868

Kathy L Ahern, RN BSN CDE Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 601 E 14th St, Sedalia, MO 65301 Phone: 660-827-9334    Fax: 660-829-7768

Gail Elizabeth Meyer, APRN, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3300 W 10th St, Sedalia, MO 65301 Phone: 660-827-0423

Ms. Andrea Nicole Petersen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2410 S Limit Ave, Sedalia, MO 65301 Phone: 573-814-1170    Fax: 573-530-1037

Janice Renee Johnson, RN, BSN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 601 E 14th St, Sedalia, MO 65301 Phone: 660-827-9474    Fax: 660-829-6618

Susan Gardner Moreau, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23738 Anderson School Rd, Sedalia, MO 65301 Phone: 660-553-1233

News Archive

60% of surgical reconstruction for ACL could be avoided: KANON study

Anterior cruciate ligament (ACL) injuries are common injuries to the knee, primarily affecting young people who practise sport and often treated with surgical reconstruction. A research group from Lund University has now shown that 60 per cent of these operations could be avoided, without negatively affecting treatment outcomes.

A mysterious form of cell death uncovers prime suspect for new cancer drug development

A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.

Intarcia presents ITCA 650 Phase 2 study results at 70th ADA

Intarcia Therapeutics, Inc. presented today the results of a phase 2 clinical study of ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual Conference of the American Diabetes Association in Orlando, FL (June 25-29, 2010). Results of the phase 2 study demonstrated substantial reductions in HbA1c and body weight during the 12 weeks of treatment with ITCA 650 at both the 20 mcg/day and 40 mcg/day doses.

Antibiotics have significant resistance effects on individual patients in primary care

Antibiotics prescribed in primary care make a considerable contribution to the problem of antimicrobial resistance, both in individual patients and the population as a whole, according to research from the University of Bristol published in this week's BMJ.

Read more Medical News

› Verified 4 days ago